Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Healthcor Management LP and Pacira Pharmaceuticals Inc. (PCRX)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
HealthCor Management 0 2,500,000 0 6.2%
HealthCor Associates 0 2,500,000 0 6.2%
HealthCor Offshore Master Fund 0 782,520 0 1.9%
HealthCor Offshore GP 0 782,520 0 1.9%
HealthCor Group 0 1,275,000 0 3.2%
Arthur Cohen 0 2,500,000 0 6.2%
Joseph Healey 0 2,500,000 0 6.2%
HealthCor Sanatate Offshore Master Fund 0 492,480 0 1.2%
HealthCor Offshore II GP 0 492,480 0 1.2%
Arthur B Cohen And Joseph Healey
Arthur B Cohen And Joseph Healey
Healthcor Management LP

Page 1 of 15 – SEC Filing

SECURITIES & EXCHANGE COMMISSION

Washington, D.C. 20549

———————-

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT

TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED

PURSUANT TO RULE 13d-2

(Amendment No. )*

Pacira Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

695127100

(CUSIP
Number)

August
3, 2017

(Date of Event Which Requires Filing of
this Statement)

Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:

¨
Rule 13d-1(b)

x   Rule
13d-1(c)

¨    Rule
13d-1(d)

(Page 1 of 17 Pages)

*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of
this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Follow Pacira Pharmaceuticals Inc. (NASDAQ:PCRX)
Trade (NASDAQ:PCRX) Now!
Loading...